1135 related articles for article (PubMed ID: 20439832)
21. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study.
Praharaj SK; Ram D; Arora M
J Affect Disord; 2009 Oct; 117(3):146-50. PubMed ID: 19178948
[TBL] [Abstract][Full Text] [Related]
22. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS).
Brakemeier EL; Luborzewski A; Danker-Hopfe H; Kathmann N; Bajbouj M
J Psychiatr Res; 2007 Aug; 41(5):395-403. PubMed ID: 16554071
[TBL] [Abstract][Full Text] [Related]
23. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation.
Sachdev PS; Loo CK; Mitchell PB; McFarquhar TF; Malhi GS
Psychol Med; 2007 Nov; 37(11):1645-9. PubMed ID: 17655805
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
[TBL] [Abstract][Full Text] [Related]
25. Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients.
Walpoth M; Hoertnagl C; Mangweth-Matzek B; Kemmler G; Hinterhölzl J; Conca A; Hausmann A
Psychother Psychosom; 2008; 77(1):57-60. PubMed ID: 18087209
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic efficacy and safety of repetitive Transcranial Magnetic Stimulation in depressions of the elderly: a review].
Jalenques I; Legrand G; Vaille-Perret E; Tourtauchaux R; Galland F
Encephale; 2010 Jun; 36 Suppl 2():D105-18. PubMed ID: 20513453
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.
Cohen RB; Boggio PS; Fregni F
Depress Anxiety; 2009; 26(7):682-8. PubMed ID: 19170101
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study.
Mishra BR; Nizamie SH; Das B; Praharaj SK
Addiction; 2010 Jan; 105(1):49-55. PubMed ID: 20078462
[TBL] [Abstract][Full Text] [Related]
29. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption.
Amiaz R; Levy D; Vainiger D; Grunhaus L; Zangen A
Addiction; 2009 Apr; 104(4):653-60. PubMed ID: 19183128
[TBL] [Abstract][Full Text] [Related]
30. Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression.
Aguirre I; Carretero B; Ibarra O; Kuhalainen J; Martínez J; Ferrer A; Salva J; Roca M; Gili M; Montoya P; Garcia-Toro M
J Affect Disord; 2011 May; 130(3):466-9. PubMed ID: 21093060
[TBL] [Abstract][Full Text] [Related]
31. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
[TBL] [Abstract][Full Text] [Related]
32. The effects of repetitive transcranial magnetic stimulation on depressive symptoms and the P(300) event-related potential.
Möller AL; Hjaltason O; Ivarsson O; Stefánsson SB
Nord J Psychiatry; 2006; 60(4):282-5. PubMed ID: 16923636
[TBL] [Abstract][Full Text] [Related]
33. The effects of 10 Hz repetitive transcranial magnetic stimulation on resting EEG power spectrum in healthy subjects.
Griskova I; Ruksenas O; Dapsys K; Herpertz S; Höppner J
Neurosci Lett; 2007 May; 419(2):162-7. PubMed ID: 17478041
[TBL] [Abstract][Full Text] [Related]
34. Transcranial direct current stimulation priming of therapeutic repetitive transcranial magnetic stimulation: a pilot study.
Loo C; Martin D; Pigot M; Arul-Anandam P; Mitchell P; Sachdev P
J ECT; 2009 Dec; 25(4):256-60. PubMed ID: 19440158
[TBL] [Abstract][Full Text] [Related]
35. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
[TBL] [Abstract][Full Text] [Related]
36. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
[TBL] [Abstract][Full Text] [Related]
37. A single session of rTMS over the left dorsolateral prefrontal cortex influences attentional control in depressed patients.
Vanderhasselt MA; De Raedt R; Baeken C; Leyman L; D'Haenen H
World J Biol Psychiatry; 2009; 10(1):34-42. PubMed ID: 19673086
[TBL] [Abstract][Full Text] [Related]
38. Intensive rTMS applications in difficult to treat psychiatric patients: some cases.
Zeeuws D; Santermans L; Baeken C; Vanderbruggen N
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S135-6. PubMed ID: 21057422
[TBL] [Abstract][Full Text] [Related]
39. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
Lisanby SH; Husain MM; Rosenquist PB; Maixner D; Gutierrez R; Krystal A; Gilmer W; Marangell LB; Aaronson S; Daskalakis ZJ; Canterbury R; Richelson E; Sackeim HA; George MS
Neuropsychopharmacology; 2009 Jan; 34(2):522-34. PubMed ID: 18704101
[TBL] [Abstract][Full Text] [Related]
40. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
